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INTRODUCTION 
Toxoplasmosis is a parasitic infection which is induced by 
Toxoplasma gondii and has various clinical symptoms [1]. Infec-
tion with this parasite occurs as the result of eating uncooked 
foods as well as water and vegetables contaminated with cat 
feces [2]. When a woman eats Toxoplasma oocysts or cysts for 
the first time during pregnancy, tachyzoites spread all over the 
body through the blood [3]. The fetus becomes infected with 
the Toxoplasma parasite which enters its blood flow via the pla-
centa. The infection of mother before pregnancy rarely puts 
the fetus in danger unless in patients with immune system de-
ficiencies [4]. 
Congenital toxoplasmosis generally occurs when the moth-
er gets infected with Toxoplasma newly during pregnancy which 
can lead to various infections in the fetus and infant such as 
abortion, stillbirth, and live birth of a child with classic symp-
toms of toxoplasmosis like hydrocephaly, microcephaly, cere-
bral calcifications, and retinochoroiditis [5,6]. The risk of 
transfer after primary infection varies from 25% (in the first 
trimester) to 65% (in the last trimester); however, the younger 
fetuses are more susceptible to this infection [7]. 
In Iran, the rate of abortion as the result of toxoplasmosis is 
unknown. Most of the studies to date about the abortions sus-
pected to be the result of Toxoplasma have been conducted 
based on the serological findings about mothers. In this study, 
we investigated the use of nested PCR (nPCR) method for the 
isolation of 529 bp element in the placenta and ELISA method 
for the detection of anti-Toxoplasma antibodies in mothers who 
had experienced abortion in Ardabil, north-west of Iran.
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Abstract: Primary maternal infection with toxoplasmosis during pregnancy is frequently associated with transplacental 
transmission of the parasite to the fetus. This study was conducted to test the utility of PCR assay to detect recent infec-
tions with Toxoplasma in aborted women at various gestational ages who referred to Obstetrics and Gynecology Depart-
ment of Alavi Hospital in Ardabil during 2014 and 2016. Two hundred women with a history of single or repeated abortion 
were investigated in this study. Blood samples were tested for specific anti-Toxoplasma IgM and IgG antibodies by ELISA. 
According to the results, 53.5% of the women under study were positive for anti-Toxoplasma antibodies: 4.0% of them 
had IgM, 43.0% had IgG, and 6.5% had both IgM and IgG. Subsequently, Nested-PCR analysis was used to detect T. 
gondii DNA in the placenta of subjects. In 10.5% of the women, the results were positive for 529 bp element of T. gondii. 
Among them, 5 (23.8%) cases were IgM positive, 1 (4.8%) case was IgG positive, and 11 (52.4%) were both IgM and IgG 
positive. In 4 (19.0%) patients, none of the antibodies were found to be positive. In total, 16 patients had positive results 
in both ELISA and PCR methods, and 174 cases had negative results for new infection. The findings of this study re-
vealed that T. gondii might be one of the significant factors leading to abortion, and that the analysis of placenta can be 
important in order to achieve increased detection sensitivity. 
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MATERIALS AND METHODS
In this study, we investigated 200 women who had experi-
enced abortion in different gestational ages and referred to 
Obstetrics and Gynecology Department of Alavi Hospital in 
Ardabil during 2014 and 2016. The study protocol was ap-
proved by the scientific committee of Ardabil University of 
Medical Sciences with the approval code of 9206. 
Sample collection
Three ml of venous blood was drawn from each patient and 
their serums were isolated. About 20 g of the placenta samples 
of the same patients were cut in sterilized conditions and 
stored together with the serum samples at the temperature of 
-20˚C until conducting the tests. The sera of all cases were test-
ed for the presence of specific IgM and IgG anti-Toxoplasma an-
tibodies via ELISA kits (Biokit, Barcelona, Spain) according to 
the manufacturer's instructions. For each patient, a question-
naire including the mother’s age, gestational age, and the his-
tory of prior abortion was completed. 
DNA extraction and PCR detection:
T. gondii DNA was extracted from the placenta of the abort-
ed women using the QIAamp DNA mini kit (Qiagen, Courta-
boeuf, France) according to the manufacturer's instructions.
Detection procedures sets were used for amplifying fragments 
of 529 bp element as described by Su et al. [8]. The external 
primers were Tox-8: GACGTCTGTGTCACGTAGAAAG and Tox-
5: CTGCAGACACAGTGCATCT GG ATT producing an amplified 
product of 450 bp. Internal primers were Tox-9: AGGAGAGA-
TATCAGGACTGTAC and Tox-II: GCGTCGTCTCGTCTAGATCG 
producing an amplified product of 162 bp. The reactions mix-
ture contained 40 μl mixture of 5 μl 10×PCR buffer, 4 μl 25 
mM MgCl2, 4 μl dNTPs (2.5 mM each), 0.2 μl FastStart Taq (5 
U/µl), 0.30 µl external forward primer (50 µM), and 0.30 µl ex-
ternal reverse primer (50 µM) added with 10 μl template DNA. 
The following conditions were used to amplify the target DNA: 
one cycle of 5 min initial denaturation at 95˚C followed by 30 
cycles at 94˚C for 30 sec, 55˚C for 1 min, and 72˚C for 2 min. 
Amplification was performed using thermal cycler. All PCR 
products, regardless of the presence or absence of a visible band 
were subjected to a second round of PCR.
The nPCR reaction was performed using 5 μl of the first PCR 
reaction in a mixture containing the inner primers at final con-
centration of 45 μl mixture of 5 μl 10×PCR buffer, 4 μl 25 
mM MgCl2, 4 μl dNTPs (2.5 mM each), 0.2 μl Fast Start Taq (5 
U/µl), 0.30 µl nested forward primer (50 µM), and 0.30 µl 
nested reverse primer (50 µM). Amplification was carried out 
at 95˚C for 5 min (one cycle), then followed by 30 cycles at 
94˚C for 30 sec, 55˚C for 1 min, and 72˚C for 1 min. The am-
plification products were detected by gel electrophoresis using 
2% agarose gel in 1×Tris–borate–EDTA buffer. DNA bands 
were visualized in the presence of ultraviolet light following 
the staining with 0.5% ethidium bromide.
Analysis of data
The minimum and maximum range of Toxoplasma-induced 
abortion prevalence and the level of agreement (kappa statis-
tics, SPSS 16, Chicago, Illinois, USA) were measured to ana-
lyze any association between congenital infection by T. gondii 
and the 2 different diagnostic techniques employed [11]. The 
chi-square test was used to analyze the association between 
congenital infection and the demographic characteristics of 
the mothers who had abortion. 
RESULTS
Demographic characteristics of mothers who had 
abortion 
The age range of the patients included in the study was 16-
41 years and their mean age was 30.5 years. Forty-three sub-
jects were under 20 years old, 88 of them were between 20 and 
30 years old, and 69 of them were over 30 years old. According 
to the data collected, most of the patients (53.0%) were in the 
first trimester of pregnancy. The patients in the second and 
third trimester of pregnancy were 31.0% and 16.0%, respec-
tively (Table 1). Moreover, 71.0% of them did not have prior 
abortion experience. Hypothyroidism, diabetes, and allergies 
were found respectively in 8 (4.0%), 9 (4.5%), and 5 (2.5%) 
patients while 178 cases (84.0%) had no history of diseases 
except miscarriage.
Serology
In this study, samples from the women who had abortion 
were investigated for the presence of anti-Toxoplasma IgG and 
IgM antibodies using ELISA method. The analysis indicated 
positive results for anti-Toxoplasma antibodies in 53.5% of the 
patients: 43.0% tested positive for only anti-Toxoplasma IgG 
antibodies, 6.5% tested positive for both anti-Toxoplasma IgG 
and IgM antibodies, and 4.0% indicated positive results for 
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only anti-Toxoplasma IgM antibodies (Tables 1, 2).
PCR and nPCR
In this study, in addition to serological diagnosis method, 
PCR method was also used to investigate the presence of Toxo-
plasma DNA in the placenta of the patients under study. All 
PCR products in the first round were included in the second 
round of PCR. Using this method, from among the 200 pa-
tients under study, Toxoplasma infection was diagnosed in 21 
(10.5%) samples based on nPCR (Fig. 1). In 17 of the samples 
with positive results, both the 450 bp and the 162 bp bands 
were detectable, but in 4 of them, just the 162 bp band was 
detected in nPCR. Among the 21 patients for whom nPCR was 
reported to be positive, 5 (23.8%) cases were IgM positive, 1 
(4.8%) was IgG positive, and 11 (52.4%) were both IgM and 
IgG positive. In 4 (19.0%) patients, none of the antibodies 
were found to be positive. 
Correlation between demographic characteristics of 
mothers and infection
ELISA and nPCR results and data from questionnaires were 
analyzed employing chi-square statistical test with 95% confi-
dence interval using SPSS software version 16. No significant 
association was found between the presences of Toxoplasma 
DNA and mother's age (P=0.23), history of abortion (P=0.08), 
and gestational age (P=0.16). There was also no significant as-
sociation between positive serological samples (IgM positive 
and both IgM and IgG positive) and mother's age (P=0.18), 
history of abortion (P=0.06), and gestational age (P=0.15). 
Agreement between ELISA and nPCR methods
Among all samples, maternal seroprevalence (anti-Toxoplas-
ma IgM antibodies) was 5.8% to 14.2% (95% confidence in-
terval) and the estimated abortion prevalence associated with 
T. gondii based on PCR was calculated to be from 6.3% to 
14.7% (95% confidence interval). Results show moderate logi-
cal agreement between the 2 different tests (κ=0.44). (A value 
of kappa equal to +1 implies perfect agreement between the 2 
raters, while that of -1 implies perfect disagreement) [9].
DISCUSSION
The detection of infective agents in pregnancy is very impor-
tant since they not only threaten the mother’s health but also 
cause fetal abnormalities [10]. According to the findings of the 
Table 1. Demographic characteristics of mothers who had abortion and results of different diagnostic techniques    
No.
PCR ELISA Both PCR and ELISA
Positive Negative IgM+ IgG+ IgG&IgM+ Ig- Positivea Negativeb
Age groups (year) ≤20
20-30
≥30
43
88
69
4
10
7
39
78
62
2
4
2
13
31
42
3
5
5
25
48
20
3
8
6
23
47
19
Gestational age 1st trimester
2th trimester
3th trimester
106
62
32
11
8
2
95
54
30
4
4
0
27
28
31
6
6
1
69
24
0
8
8
1
67
22
0
History of abortion Yes
No
58
142
3
18
55
124
0
8
31
55
2
11
25
68
1
16
23
66
aPCR positive and ELISA positive (IgG positive+IgM positive+IgG and IgM positive).       
bPCR negative and ELISA negative (Ig negative).  
Table 2. ELISA and nested PCR results in samples 
Methods
nPCR
No.
Positive Negative
ELISA IgG Positive
IgM Positive
IgG & IgM Positive
Negative
No.
1
5
11
4
21
85
3
2
89
179
86
8
13
93
200
Fig. 1. Agarose gel electrophoresis of nested PCR products of 
tissue samples of aborted placenta with the internal 529 bp ele-
ment primers. Lane M, molecular marker; lane 1, T. gondii posi-
tive control (type 1; RH strain); lane 18 negative control; lane 2-17 
samples.
162 bp
M 1 2 3 4 5 6 7 8 9 10 11 1213 14 1516 17 18
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previous studies, mother’s infection in the first and second tri-
mester might lead to the death of fetus in 5% and 2% of the 
cases, respectively [1-11]. The incidence rate of congenital 
toxoplasmosis is approximately 1.5 cases per 1,000 live births, 
so the estimated global incidence of congenital toxoplasmosis 
is 190,100 cases per year [12].
A series of techniques are required to make a definitive diag-
nosis in the abortions occurred as the result of toxoplasmosis 
[13]. Suzuki et al. [14] conducted the evaluation of IgM via 
isolating the SAG 1 gene of Toxoplasma in placenta and con-
cluded that the evaluation of placenta in order to detect Toxo-
plasma genome can be very helpful for the rapid diagnosis of 
congenital toxoplasmosis.
In 2000, the 200- to 300-fold repetitive 529 bp DNA frag-
ment was identified in T. gondii genome and researchers re-
ported high sensitivity and great feature of PCR method in de-
tecting this parasite [15]. In 2003, 529 bp DNA fragment was 
introduced as a new alternative for 18S ribosomal DNA and 
B1 targets in detecting Toxoplasma DNA in congenital toxoplas-
mosis [16]. The rate of Toxoplasma-induced abortion has been 
different in studies (18.3% in Egypt [17], 5.3% in Brazil [18], 
15.5% in Isfahan, Iran [19], 14.4% in Shiraz, Iran [20], and 
11.0% in France [21]. Sarkari et al. [22] analyzed the aborted 
fetuses for which the PCR test was positive using immunohis-
tochemistry (IHC) method and did not observe any cyst or 
tachyzoitein them. The reason for this might be the low num-
ber of parasites in the aborted tissues.
In our study, a moderate agreement between the 2 different 
tests was found with 95% confidence interval (κ=0.44). This 
finding indicates the need for more research in order to shed 
light on the methods of infection transfer and also the level of 
transfer after getting infected. 
Although getting serological tests is one of the main diag-
nostic methods used for the detection of toxoplasmosis, it has 
many limitations. This method might not be able to detect 
special anti-Toxoplasma antibodies during the active phase of 
infection since these antibodies might not be produced until 
several weeks after parasitaemia. Moreover, this method might 
be unsuccessful in detecting T. gondii infection in individuals 
with immune system deficiencies due to the lack of appropri-
ate antibodies production. Therefore, using PCR method in 
detecting infection with T. gondii obviates the problems en-
countered when using serological methods, and also when 
dealing with patients having complicated problems. Thus, the 
results obtained simultaneously from PCR and ELISA meth-
ods can definitively confirm the infection [23].
The presence of Toxoplasma DNA in 4.3% of the women for 
whom the results of serological test were negative might sug-
gest the existence of a new infection at the time of getting sam-
ples which shows that the immune system either has not been 
able to produce enough immunoglobulins to detect it in serol-
ogy method or suffers from degrees of immunodeficiency. A 
positive result of a serological test only shows the presence of 
an infection whereas the direct detection of T. gondii in clinical 
samples can confirm the presence of parasites which them-
selves can be primary, reactivated, or chronical infections [24]. 
Our findings indicate that toxoplasmosis is a big danger and a 
main risk factor in increasing the probability of abortion in 
pregnant women in this part of Iran. Therefore, we recom-
mend that in order to increase detection sensitivity, molecular 
test of placenta be conducted for each abortion even if the re-
sults of serological tests are negative.
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